Figure 4.

RhoBTB3 is part of a CUL3–ubiquitin ligase complex on the Golgi that targets Cyclin E. (A) Colocalization of transfected GFP-RhoBTB3 and FLAG-CUL3 on the Golgi of HeLa cells, detected with anti-GCC185 antibodies. Bar, 20 µm. Insets, enlarged Golgi regions. Bar, 2 µm. (B) GFP-RhoBTB3 binds 3XFLAG-CUL3. Total cell extract inputs (2%) are shown at left; anti-GFP bound material is shown at right, detected by immunoblot. (C) Interaction of RhoBTB3 with FLAG-CUL3 and HA-RBX1 in membranes from HEK293T cells. Cells were transfected as indicated at the top, immunoprecipitated with anti-FLAG antibody, and bound proteins detected by immunoblot with antibodies to the proteins indicated at right. Molecular mass marker mobility is shown at the left in kilodaltons. C, cytosol; M, membrane. (D) Schematic diagram of a canonical CUL3–ubiquitin ligase complex. The N-terminal domain (NTD) of CUL3 interacts with the RING E3 ubiquitin ligase RBX1; the C-terminal domain (CTD) binds a BTB domain–containing substrate adaptor (i.e., RhoBTB3). (E) Interaction of FLAG-RhoBTB3 with HA-RBX1 after 72 h of control or CUL3 siRNA depletion in HEK293T cells. Inputs are at left (5%); anti-FLAG precipitates in duplicate are at right, immunoblotted with anti-FLAG (top) or anti-HA (bottom). Quantitation of coprecipitated RBX1 is shown in relative values at the bottom of the anti-HA panel. (E) CUL3 depletion disrupts the Golgi but does not release RhoBTB3 from the Golgi. Bar, 5 µm. (F) Interaction of RhoBTB3 with Cyclin E on membranes. Membrane extracts from cells cotransfected with indicated constructs were immunoprecipitated and analyzed as in C. Molecular mass marker mobility is shown at the left in kilodaltons.

or Create an Account

Close Modal
Close Modal